89590-95-4
Chemical Structure
Mogroside IV
- CAS No.: 89590-95-4
- Formula:C54H92O24
- Molecular Weight:1125.29
IUPAC Name: (2S,3R,4S,5S,6R)-2-(((2S,3R,4S,5S,6R)-4,5-dihydroxy-2-(((3R,6R)-2-hydroxy-6-((3S,8R,9R,10R,11R,13R,14S,17R)-11-hydroxy-4,4,9,13,14-pentamethyl-3-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-((((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)methyl)tetrahydro-2H-pyran-2-yl)oxy)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methylheptan-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
InChIKey: WRPAFPPCKSYACJ-KGFBLRRZSA-N
SMILES: CC(O)(C)[C@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@H](C)[C@H]3CC[C@@]4(C)[C@@]5([H])CC=C6C(C)(C)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]8[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O8)O7)CC[C@@]6([H])[C@]5(C)[C@H](O)C[C@@]43C
Biological Activity: Mogroside IV is a pancreatic lipase inhibitor with a IC50 of 289.09 µg/mL. Mogroside IV inhibits pancreatic lipase in a dose-dependent manner. Mogroside IV can be used in research related to obesity[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Mogroside IV | 98.57% | Mogroside IV is a pancreatic lipase inhibitor with a IC50 of 289.09 µg/mL. Mogroside IV inhibits pancreatic lipase in a dose-dependent manner. Mogroside IV can be used in research related to obesity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Mogroside IV (Standard) | ≥98% | Mogroside IV (Standard) is the analytical standard of Mogroside IV (HY-N6945). This product is intended for research and analytical applications. Mogroside IV is a pancreatic lipase inhibitor with a IC50 of 289.09 µg/mL. Mogroside IV inhibits pancreatic lipase in a dose-dependent manner. Mogroside IV can be used in research related to obesity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
- [1]. Sun B S, et al. Anti-obesity effects of mogrosides extracted from the fruits of Siraitia grosvenorii (Cucurbitaceae). African Journal of Pharmacy and Pharmacology. 2012;6(20):1492-1501.
- [2]. Chen H Y, et al. Production of Siamenoside I and Mogroside IV from Siraitia grosvenorii Using Immobilized β-Glucosidase. Molecules. 2022;27:6352.
Keywords